Suchergebnisse - "Menter, Alan"

PubPharm (5)

1

Adalimumab in paediatric psoriasis

enthalten in: Lancet (London, England) | 2017

von Kivelevitch, D. | Menter, A.

CommentOn: Lancet. 2017 Jul 1;390(10089):40-49. - PMID 28478975

2

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3) : results from two phase 3 randomised trials

enthalten in: Lancet (London, England) | 2015

von Griffiths, C. | Reich, K. | Lebwohl, M. | +114

CommentIn: Lancet. 2015 Aug 8;386(9993):510-2. - PMID 26072106

3

Ponesimod--a future oral therapy for psoriasis?

enthalten in: Lancet (London, England) | 2014

von Ryan, C. | Menter, A.

CommentOn: Lancet. 2014 Dec 6;384(9959):2036-45. - PMID 25127208

4

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis : randomised, double-blind, placebo-controlled, crossover trial

enthalten in: Lancet (London, England) | 2009

von Gottlieb, A. | Menter, A. | Mendelsohn, A. | +6

ErratumIn: Lancet. 2009 Apr 18;373(9672):1340

5

Current and future management of psoriasis

enthalten in: Lancet (London, England) | 2007

von Menter, A. | Griffiths, C.

1
[1]